Table 2 Perioperative and Postoperative Characteristics of the Study Population
Variablea | All subjects (n = 610) | Non- XRT Group (n = 535) | C-XRT Group (n = 75) | P value |
|---|---|---|---|---|
TAVR Access/duration | ||||
 Femoral Access | 535 (87.7) | 472 (88.22) | 63 (84.0) | 0.34 |
 Median Procedure duration (hrs:mins/ interquartile) | 2:17 (1:40–2:48) | 2:16 (1:04–3:28) | 2:23 (1:29–3:07) | 0.38 |
Valve types | ||||
 Edwards Sapien | 500 (81.9) | 438 (81.87) | 62 (82.67) | 0.86 |
 Core Valve | 110 (18.1) | 97 (18.13) | 13 (17.33) | |
Post-procedure parameters | ||||
 Mod-severe Paravalvular leak | 9 (1.48) | 8 (1.5) | 1 (1.35) | 0.91 |
 Post-procedure Hb | 9.66 ± 1.75 | 9.73 ± 1.76 | 9.12 ± 1.6 | 0.004 |
 Post-procedure Creatinine | 1.52 ± 1.34 | 1.50 ± 1.28 | 1.64 ± 1.7 | 0.41 |
 Creatinine at discharge | 1.3 ± 1.1 | 1.3 ± 1.1 | 1.28 ± 1.1 | 0.73 |
 Post TAVR LVEF | 55.05 ± 12.4 | 54.72 ± 12.74 | 57.4 ± 9.8 | 0.081 |
 Post TAVR AVA, cm2 | 1.90 ± 0.49 | 1.91 ± 0.49 | 1.87 ± 0.5 | 0.53 |
 Post TAVR Peak gradient, mm Hg | 7.93 ± 4.64 | 7.94 ± 4.59 | 7.87 ± 5 | 0.9 |
 Post TAVR mean gradient, mm Hg | 3.62 ± 2.28 | 3.62 ± 2.23 | 3.64 ± 2.6 | 0.94 |